Skip to main content
OpenTrials

Clinical trial condition

Carbohydrate Metabolism, Inborn Errors

Explore clinical trials studying Carbohydrate Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

546 public trials 96 recruiting studies
Refine in advanced search Browse all conditions

Carbohydrate Metabolism, Inborn Errors trial results

Completed

Safety and Dose Ranging Study of Insulin Receptor MAb-IDUA Fusion Protein in Patients With MPS I

NCT02371226

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +9 more
Locations
  • Children's Hospital Oakland Oakland, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Emory Healthcare Decatur, Georgia, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
View Trial Details
Completed

MRI in McArdle Disease (GSDV)

NCT03844022

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +5 more
Locations
  • Copenhagen Neuromuscular Center, Rigshospitalet Copenhagen, Denmark
View Trial Details
Completed

Safety and Dose-Finding Study of DTX401 (AAV8G6PC) in Adults With Glycogen Storage Disease Type Ia (GSDIa)

NCT03517085

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, GSD1, +7 more
Locations
  • UCONN Health Farmington, Connecticut, United States
  • Michigan Medicine University of Michigan Ann Arbor, Michigan, United States
  • UT Health - McGovern Medical School Houston, Texas, United States
  • Montreal Children Hospital, McGill University Health Centre Montreal, Quebec, Canada
View Trial Details
Completed

A Study of JR-141 in Patients With Mucopolysaccharidosis II

NCT03568175

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +16 more
Locations
  • Fukui Clinical site Fukui, Japan
  • Fukuoka Clinical site 2 Fukuoka, Japan
  • Fukuoka Clinical site Fukuoka, Japan
  • Gifu Clinical site Gifu, Japan
View all 19 locations
View Trial Details
Completed

A Study of JR-141 in Patients With Mucopolysaccharidosis Type II

NCT03128593

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +16 more
Locations
  • Gifu Clinical site Gifu, Japan
  • Fukuoka Clinical site Kurume, Japan
  • Tokyo clinical site1 Minato, Japan
  • Osaka Clinical site1 Osaka, Japan
View Trial Details

Related conditions